(Q34470150)

Revision as of 13:16, 29 December 2021 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Histone deacetylase inhibitors: discovery and development as anticancer agents)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

Histone deacetylase inhibitors: discovery and development as anticancer agents

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Histone deacetylase inhibitors: discovery and development as anticancer agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Paul A Marks

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Milos Dokmanovic

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1497-1511

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases and cancer: causes and therapies

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Binary switches and modification cassettes in histone biology and beyond.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

An increasingly complex code

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Controlling the double helix

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The nucleosome: from genomic organization to genomic regulation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone and chromatin cross-talk

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases (HDACs): characterization of the classical HDAC family

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The Sir2 family of protein deacetylases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Acetylation of proteins as novel target for antitumor therapy: review article.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of histone deacetylase activities

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and characterization of a histone deacetylase, HDAC9

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class II histone deacetylases: versatile regulators

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and characterization of the murine histone deacetylase (HDAC3).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Three proteins define a class of human histone deacetylases related to yeast Hda1p

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Isolation and characterization of mammalian HDAC10, a novel histone deacetylase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Chicken histone deacetylase-2 controls the amount of the IgM H-chain at the steps of both transcription of its gene and alternative processing of its pre-mRNA in the DT40 cell line

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Caspase-mediated specific cleavage of human histone deacetylase 4.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors in clinical development

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Expression profile of histone deacetylase 1 in gastric cancer tissues.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC6 expression is correlated with better survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone Deacetylase Inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone Deacetylase Inhibitors: The Abbott Experience

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone acetylation-mediated regulation of genes in leukaemic cells.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The role of the redox protein thioredoxin in cell growth and cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Antioxidant function of thioredoxin and glutaredoxin systems

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Prospects: histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Identifiers

10.1517/13543784.14.12.1497

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34470150&oldid=1551890196"